Taal BG - Search Results

1

High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients.

Wafelman AR, Konings MC, Rosing H, Hoefnagel CA, Taal BG, Maes RA, Beijnen JH. Wafelman AR, et al. Among authors: taal bg. J Pharm Biomed Anal. 1994 Sep;12(9):1173-9. doi: 10.1016/0731-7085(94)e0034-x. J Pharm Biomed Anal. 1994. PMID: 7803569

2

Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.

Wafelman AR, Nortier YL, Rosing H, Maessen HJ, Taal BG, Hoefnagel CA, Maes RA, Beijnen JH. Wafelman AR, et al. Among authors: taal bg. Nucl Med Commun. 1995 Sep;16(9):767-72. doi: 10.1097/00006231-199509000-00007. Nucl Med Commun. 1995. PMID: 7478409

3

Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.

Taal BG, Hoefnagel CA, Valdes Olmos RA, Boot H, Beijnen JH. Taal BG, et al. J Clin Oncol. 1996 Jun;14(6):1829-38. doi: 10.1200/JCO.1996.14.6.1829. J Clin Oncol. 1996. PMID: 8656251

4

Bioanalysis of m-iodobenzylguanidine in plasma by high-performance liquid chromatography after derivatization with benzoin.

Sparidans RW, Taal BG, Beijnen JH. Sparidans RW, et al. Among authors: taal bg. J Chromatogr B Biomed Sci Appl. 1999 Jul 9;730(2):193-9. doi: 10.1016/s0378-4347(99)00197-8. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10448954

5

Role of [131I]metaiodobenzylguanidine therapy in carcinoids.

Hoefnagel CA, Taal BG, Valdés Olmos RA. Hoefnagel CA, et al. Among authors: taal bg. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):346-8. J Nucl Biol Med (1991). 1991. PMID: 1726678

6

Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.

Taal BG, Hoefnagel CA, Valdés Olmos RA, Boot H. Taal BG, et al. Eur J Cancer. 1996 Oct;32A(11):1924-32. doi: 10.1016/0959-8049(96)00241-9. Eur J Cancer. 1996. PMID: 8943676 Clinical Trial.

7

Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.

Zuetenhorst H, Taal BG, Boot H, Valdes Olmos R, Hoefnagel C. Zuetenhorst H, et al. Among authors: taal bg. Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1157-64. doi: 10.1097/00042737-199910000-00014. Eur J Gastroenterol Hepatol. 1999. PMID: 10524647

8

Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG.

Hoefnagel CA, Taal BG, Sivro F, Boot H, Valdes Olmos RA. Hoefnagel CA, et al. Among authors: taal bg. Nucl Med Commun. 2000 Aug;21(8):755-61. doi: 10.1097/00006231-200008000-00009. Nucl Med Commun. 2000. PMID: 11039459 Clinical Trial.

9

Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.

Taal BG, Hoefnagel C, Boot H, Valdés Olmos R, Rutgers M. Taal BG, et al. Ann Oncol. 2000 Nov;11(11):1437-43. doi: 10.1023/a:1026592025862. Ann Oncol. 2000. PMID: 11142484 Free article.

10

Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours.

Zuetenhorst JM, Valdes Olmos RA, Muller M, Hoefnagel CA, Taal BG. Zuetenhorst JM, et al. Among authors: taal bg. Endocr Relat Cancer. 2004 Sep;11(3):553-61. doi: 10.1677/erc.1.00810. Endocr Relat Cancer. 2004. PMID: 15369454 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters